Gene | Disease | Score gda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
0.500 | GeneticVariation | GWASDB | Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk. | 23001122 | 2012 |
||||||||
|
|
0.500 | GeneticVariation | GWASDB | Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. | 23544013 | 2013 |
||||||||
|
|
0.200 | GeneticVariation | GWASDB | Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk. | 23001122 | 2012 |
||||||||
|
|
0.200 | GeneticVariation | GWASDB | Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. | 23544013 | 2013 |
||||||||
|
|
0.130 | GeneticVariation | GWASDB | Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. | 23544013 | 2013 |
||||||||
|
|
0.100 | GeneticVariation | GWASDB | Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. | 23544013 | 2013 |
||||||||
|
|
0.100 | GeneticVariation | GWASDB | Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk. | 23001122 | 2012 |
||||||||
|
|
0.100 | GeneticVariation | GWASDB | Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk. | 23001122 | 2012 |
||||||||
|
|
0.210 | Biomarker | RGD | Pattern of MHC class I and immune proteasome expression in Walker 256 tumor during growth and regression in Brattleboro rats with the hereditary defect of arginine-vasopressin synthesis. | 21889127 | 2011 |
||||||||
|
|
0.900 | Biomarker | HPO | |||||||||||
|
|
0.700 | Biomarker | HPO | |||||||||||
|
|
0.700 | Biomarker | HPO | |||||||||||
|
|
0.700 | Biomarker | HPO | |||||||||||
|
|
0.700 | Biomarker | HPO | |||||||||||
|
|
0.700 | Biomarker | HPO | |||||||||||
|
|
0.700 | Biomarker | HPO | |||||||||||
|
|
0.700 | Biomarker | HPO | |||||||||||
|
|
0.700 | Biomarker | HPO | |||||||||||
|
|
0.700 | Biomarker | HPO | |||||||||||
|
|
0.700 | Biomarker | HPO | |||||||||||
|
|
0.700 | Biomarker | HPO | |||||||||||
|
|
0.500 | Biomarker | HPO | |||||||||||
|
|
0.500 | Biomarker | HPO | |||||||||||
|
|
0.500 | Biomarker | HPO | |||||||||||
|
|
0.500 | Biomarker | HPO |